Author:
Khorasani Mohammadali,Law Calvin H. L.,Myrehaug Sten,Singh Simron,Assal Angela,Hsieh Eugene,Cukier Moises,Hallet Julie
Publisher
Springer International Publishing
Reference113 articles.
1. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335.
2. Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121:589.
3. National Cancer Institute Surveillance, Epidemiology, End Results Program. Cancer Stat Facts [Internet]. National Institutes Heal [Cited 2017 Nov]. Available from https://doi.org/10.1007/SeerCancerGov/Statfacts .
4. Kunz PL. Understanding neuroendocrine tumors – a NET gain. JAMA Oncol. 2017;3:1343–4.
5. Parren A, Couvelard A, Scoazec J, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology, diagnosis and prognostic stratification. Neuroendocrinology. 2017;105:196–200.